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Abstract
We have previously demonstrated that B cells can shape the immune response to Mycobacterium tuberculosis, including the
level of neutrophil infiltration and granulomatous inflammation at the site of infection. The present study examined the
mechanisms by which B cells regulate the host neutrophilic response upon exposure to mycobacteria and how neutrophilia
may influence vaccine efficacy. To address these questions, a murine aerosol infection tuberculosis (TB) model and an
intradermal (ID) ear BCG immunization mouse model, involving both the mMT strain and B cell-depleted C57BL/6 mice, were
used. IL (interleukin)-17 neutralization and neutrophil depletion experiments using these systems provide evidence that B
cells can regulate neutrophilia by modulating the IL-17 response during M. tuberculosis infection and BCG immunization.
Exuberant neutrophilia at the site of immunization in B cell-deficient mice adversely affects dendritic cell (DC) migration to
the draining lymph nodes and attenuates the development of the vaccine-induced Th1 response. The results suggest that B
cells are required for the development of optimal protective anti-TB immunity upon BCG vaccination by regulating the IL-
17/neutrophilic response. Administration of sera derived from M. tuberculosis-infected C57BL/6 wild-type mice reverses the
lung neutrophilia phenotype in tuberculous mMT mice. Together, these observations provide insight into the mechanisms
by which B cells and humoral immunity modulate vaccine-induced Th1 response and regulate neutrophila during M.
tuberculosis infection and BCG immunization.
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Introduction
It has recently been demonstrated that B cells can shape the
development of the immune response to Mycobacterium tuberculosis
[1,2]. The lungs of M. tuberculosis-infected B cell-deficient mice
display exacerbated inflammation, with enhanced neutrophil
recruitment [1]. Neutrophils are among the earliest cells to
migrate to the site of M. tuberculosis infection and evidence exists
that these phagocytes participate in the granulomatous reaction
[3,4]. Enhanced neutrophil infiltration has been associated with
excessive lung pathology and with poor bacillary control in
genetically susceptible mice [5,6]. It has been proposed that
neutrophilia is indicative of failed Th1 immunity in response to
aerosol M. tuberculosis challenge [7]. There is also evidence
suggesting that interaction of M. tuberculosis with neutrophils
enhances DC migration to the draining lymph nodes thereby
promoting the initiation of adaptive immune response in an
aerogenic tuberculous infection [8]. Studies examining the
significance of neutrophils in protection against M. tuberculosis
have yielded conflicting results [3,5,9,10,11,12,13,14], and the role
of these professional phagocytes in TB remains to be clearly
defined.
The cytokine IL-17 plays an important role in the recruitment
of neutrophils to the site of inflammation [15,16,17,18], including
the airways, during infection [19,20]. In autoimmune diseases and
infection, IL-17 is produced by a variety of host cells, including
myeloid cells [21], invariant natural killer (iNK) T cells [22], NK
cells [23,24], cd T cells [25,26,27], and Th17 cells, a subset of
helper CD4+ T lymphocytes [17,28]. In a BCG immunization
model, IL-17 produced by Th17 cells can downregulate IL-10
production and subsequently drives Th1 responses [29]. BCG
vaccination induces Th17 cells that populate the lungs of
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immunized mice [30]. Upon challenge with M. tuberculosis, the
Th17 cells recruit Th1 cells to the site of infection to restrict
mycobacterial growth [30]. IL-17 can, however, promote tissue
damage during M. tuberculosis infection [17,31] and in the context
of other infectious and autoimmune diseases [15,16,32,33,34]. It
has been shown that repeated BCG vaccinations enhanced IL-17
production that is associated with increased neutrophil recruit-
ment and exacerbated lung tissue pathology [35]. Therefore, a
protective immune response against M. tuberculosis should promote
Th17-mediated protection while mitigating the tissue damaging
effects.
Ample evidence support the notion that B cells and the humoral
immune response modulate T cell immunity [36,37], including the
development of memory T cell responses during infection [36,37]
and vaccine-induced protection against secondary challenge with
intracellular pathogens such as Chlamydia [38] and Francisella
[39]. Experimental evidence suggests that humoral immunity plays
a role in regulating the Th1 response in TB [2]. Results derived
from an X-linked immune-deficient (xid) B cell-deficient mouse
model suggest that neutrophilia may adversely affect BCG vaccine
efficacy [40]. Recent studies involving the B cell-depleting agent
rituximab have revealed that B cells may enhance or diminish the
IL-17/Th17 response [41,42,43,44]. It has recently been reported
that a subset of B cells in the blood of humans with tuberculous
infection can suppress Th17 response [45].
These observations on B cells have prompted us to examine the
role of B cells in regulation of IL-17 and neutrophilic responses to
mycobacteria using an acute aerosol infection model as well as an
ear ID BCG immunization model. The results provide evidence
that B cells regulate neutrophilia during M. tuberculosis infection
and BCG immunization by modulating the IL-17 response. The
study also revealed that neutrophilia at the site of immunization
adversely affects the development of BCG-induced Th1 response
by diminishing DC migration to draining lymph nodes, thereby
attenuating T cell immunity against M. tuberculosis. This latter
observation suggests that B cells can optimize BCG-elicited Th1
immunity by regulating the IL-17/neutrophilic response. Finally,
the lung neutrophilia and enhanced Th17 response seen in M.
tuberculosis-infected B cell-deficient mice could be reversed by
passive immune serum therapy, raising the possibility that
immunoglobulins (Igs) may contribute to the regulation of these
phenotypes.
Results
B cell-deficiency is associated with an augmented
inflammation and neutrophilic infiltration in the lungs of
M. tuberculosis-infected mice during the acute phase of
infection
The aberrant immune response to M. tuberculosis, including
excessive neutrophilia [1], has yet to be mechanistically explained.
Emerging evidence suggest neutrophils play a significant role in
modulating the immune response to M. tuberculosis [3,4,5,6,7,8] We
initiated studies to characterize the neutrophilic response in acute
TB in the B cell-deficient mMT mouse [1]. Flow cytometric
analysis of lung cells procured from M. tuberculosis-infected mMT
mice revealed a neutrophilic response that was significantly higher
than that observed in infected wild-type controls. At as early as 7
days post-infection (p.i.), the difference in lung neutrophilia
between the two groups of mice was, albeit small, significant
(p,0.05) (Figure 1A; Right Panel). By 21 days p.i., the absolute
number of neutrophils in the lungs of mMT mice was over two fold
that observed in wild-type animals (p,0.005). The proportion of
neutrophils in the total lung cell population was also higher in
tuberculous mMT mice relative to wild-type (Figure 1A; Left Panel
& data not shown). This pulmonic neutrophilia of M. tuberculosis-
infected mMT mice was also apparent histologically (Figure 1D&E),
and was associated with an overall enhanced inflammatory
response as assessed by histological examination of infected tissues
(Figure 1B&C) and by quantifying the total number of cells
infiltrating the lungs throughout the first month after infection
(Figure 1F). Thus, the previously observed enhanced pulmonic
neutrophil and exacerbated granulomatous inflammatory response
of tuberculous mMT mice at 1 month p.i., when adaptive
immunity sets in, is similarly observed in early acute TB, when
the predominant anti-tuberculous response is mediated via innate
immunity [1]. These data suggest that B cells can regulate the
pulmonic inflammatory response, including that involving neu-
trophils, in the early acute phase of TB.
Neutrophilia in the lungs of B cell-deficient mice with
acute TB is associated with an enhanced IL-17/Th17
response
The link between IL-17 and neutrophil recruitment [15,16], as
well as the observation suggesting a role for B cells and humoral
immunity in modulating Th1 response in TB [2] and Th17
response in autoimmune diseases [41,42,43,44,45] prompted us to
examine whether the neutrophilia observed in the lungs of mMT
mice could be due to an aberrant Th17/IL-17 response as a result
of B cell-deficiency. Flow cytometric analyses of lung cells, in
conjunction with intracellular staining, revealed that on day 21
p.i., the numbers of IL-17-producing lung cells were elevated in
tuberculous mMT mice compared to infected wild-type controls
(Figure 2A), a subset of which is CD4+ Th17 cells (Figure 2B). The
lung neutrophilia of tuberculous mMT mice could be significantly
reversed by IL-17 neutralization (Figure 2C). Lung bacterial
burden in mMT mice treated with IL-17 neutralizing antibodies
(Abs) was comparable to those treated with isotype controls,
excluding bacillary loads as a variable that may confound data
interpretation (Figure 2D). These results suggest that IL-17,
produced locally by lung cells including Th17 cells, plays a
Author Summary
Mycobacterium tuberculosis poses a serious threat to public
health globally. It has been well established that T cells are
critical in protection against M. tuberculosis. The role of B
cells and humoral immunity in the process is less well
understood. We previously showed that B cells and
humoral immunity regulate the immune response against
M. tuberculosis. The present study examined the mecha-
nisms by which B cells regulate the host neutrophilic
response upon exposure to mycobacteria and how
neutrophilia may modulate the development of vaccine-
induced protective immunity. The data reveal that B cells
can regulate neutrophilia during M. tuberculosis infection
and BCG vaccination by modulating the IL-17 response.
Vaccination studies show that excess neutrophilia adverse-
ly affects the development of BCG-elicited Th1 response.
These observations suggest that B cells can optimize the
development of protective immunity upon BCG vaccina-
tion by regulating the IL-17/neutrophilic response. Under-
standing the mechanisms by which B cells and humoral
immunity modulate the immune response during M.
tuberculosis infection and BCG immunization, particularly
those that regulate IL-17 levels and neutrophilia, may lead
to the development of novel strategies for the control of
the tubercle bacillus, including efficacious vaccines.
B Cells Regulate Neutrophilia by Modulating IL-17
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significant role in recruiting neutrophils to the lungs of B cell-
deficient mMT mice in the early phase of acute M. tuberculosis
infection and that B cells and humoral immunity play a role in
regulating the IL-17/Th17 response in TB.
B cell-depleted wild-type C57BL/6 mice also exhibit
neutrophilia and augmented Th17 response in acute TB
The previously reported B cell deficiency-associated pheno-
types, which include lung neutrophilia at 1 month after aerogenic
M. tuberculosis challenge [1], were observed in the mMT strain
rendered B cell-deficient by targeted disruption of the membrane
exon of the m chain gene [46]. That these observations are B cell-
specific is strongly supported by reversal of the B cell deficiency
phenotypes by adoptive B cell transfer [1]. Nevertheless, to
rigorously test the B cell-specificity of the Th17/IL-17/neutro-
philia phenotype observed in the mMT strain in acute TB
(Figures 1&2), we conducted experiments involving B cell
depletion via administration of CD22-cal, an effective B cell-
depleting agent [47,48] (Figure S1A), in wild-type C57BL/6 mice.
In agreement with the results of the mMT studies, neutrophilic
infiltration in the lungs of tuberculous B cell-depleted C57BL/6
mice was higher compared to that observed in undepleted controls
(Figure 3A). Neutrophilia in B cell-depleted mice was apparent as
early as 7 days after aerogenic challenge, and increased steadily
over the next 2 weeks, peaking at day 21 to day 28 post-
inoculation (Figure 3A). This neutrophilia was associated with an
Figure 1. B cell-deficiency in mMT mice is associated with an augmented lung neutrophilic and inflammatory response in M.
tuberculosis-infected mice during the acute phase of infection. Wild-type or B cell-deficient mMT mice were infected aerogenically with 200–
300 CFU of M. tuberculosis Erdman. Lungs cells were procured for cytometric analysis, in conjunction with intracellular staining, at appropriate time
intervals p.i.. A, B cell-deficient mMT mice exhibited significant elevation, relative to wild-type animals, in the percentage and in the number of
neutrophils (CD11b+Ly6G+) among lung cells during acute tuberculous infection. The FACS dot plot depicts the percentage of neutrophils at day 21
p.i.. (*p,0.05, **p,0.005). The number of neutrophils infiltrating the lungs was evaluated on day 7, 14, and 21 p.i.. The hematoxylin & eosin (H&E)-
stained lung sections revealed increased level of total cellular (B & C; 26) and neutrophilic (D & E; 1006) infiltration. During the first month p.i., total
cells infiltrating the lungs increased gradually (F), at each time point studied, the number of cells in the lungs of mMT mice was significantly higher
than that in WT’s (F). The H&E sections represent lung tissues at 2 weeks p.i.. Arrows: neutrophils. ***p,.0001; **p,.001; *p,0.01. Data presented
are representative of two to three experiments with three to five mice per group.
doi:10.1371/journal.ppat.1003472.g001
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increase in IL-17-producing lung cells (Figure 3B). As in the mMT
study, IL-17 neutralization reversed the neutrophilia phenotype in
M. tuberculosis-infected, B cell-depleted mice (Figure 3C). The
congruency of the B cell-depletion and mMT studies strongly
support that the IL-17/Th17/neutrophila phenotype is B cell-
specific, supporting a role for B cells in regulating neutrophilia in
acute TB through modulation of the IL-17 response.
B cell deficiency results in a diminished BCG vaccine-
induced Th1 response in mice
It has been suggested that neutrophilia in the B cell-deficient xid
mouse may diminish anti-TB vaccine efficacy, although the B cell-
specificity of the phenotypes and the mechanisms underlying the
enhanced neutrophilic response was not examined [40]. This
observation, together with the Th17/neutrophilia phenotype
observed in M. tuberculosis-infected B cell-deficient mice
(Figures 1–3), led us to hypothesize that B cells and humoral
immunity, by virtue of their ability to modulate the IL-17 response
and neutrophilia (Figures 1–3) upon exposure to mycobacteria,
may affect the efficacy of anti-TB vaccine. To begin testing this
hypothesis, we assessed the effects of B cell deficiency on the BCG-
induced Th1 response in mice. The results showed that upon
subcutaneous (SC) BCG immunization, B cell-deficient mice,
compared to wild-type mice, developed a significantly attenuated
Th1 response (Figure 4A). This attenuated Th1 response was also
apparent in C57BL/6 mice treated with 5D2 (Figure 4B), a highly
effective B cell-depleting anti-CD20 Ab (Figure S1B). Together,
the mMT and the 5D2 vaccination studies have provided
compelling evidence that B cells are required for optimal
development of BCG-induced Th1 response.
Characterization of the effect of B cell-deficiency on the
BCG-induced Th1 response: The ID ear vaccination
mouse model
A limitation of the SC BCG immunization mouse model, which
involves administration of the vaccine at the scruff of the neck of
Figure 2. B cell-deficiency in mMT mice is associated with an augmented lung Th17 response in tuberculous mice during the acute
phase of infection: reversibility of neutrophilia by IL-17 neutralization. Wild-type or B cell-deficient mMT mice were infected aerogenically
with 200–300 CFU of M. tuberculosis Erdman. Lungs cells were procured for cytometric analysis, in conjunction with intracellular staining, at
appropriate time intervals p.i.. A, Compared to wild-type C57BL/6s, B cell-deficient mMT mice displayed increased in the number of IL-17A-producing
lung cells and B, total number of pulmonic Th17 cells (CD3+CD4+IL-17A+) upon M. tuberculosis infection (*p,0.05). C, Quantification of neutrophil
infiltration into the lungs of B cell-deficient mMT mice following IL-17 neutralization at day 14 p.i. revealed that increased neutrophilia was reversed
via treatment with a mAb specific for this cytokine (***p,0.0005). D, this reversibility was not due to differences in bacterial burden since the total
numbers of CFU in the lungs of mAb-treated and -untreated mouse groups were comparable. Data presented are representative of two to three
experiments with three to five mice per group.
doi:10.1371/journal.ppat.1003472.g002
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the animal, is the variability in the anatomic location of the lymph
nodes to which immune cells (e.g., DCs) migrate from this site of
vaccination. In addition, it is difficult to locate the precise area of
vaccination to procure immune cells for analysis. These problem-
atic features of the SC immunization model complicate the
analysis of local immunological events that ensue upon immuni-
zation. Consequently, we adopted an ear ID vaccination model to
circumvent this hindrance, since the anatomical location of the
draining lymph nodes of the ear (the superficial cervical lymph
nodes) is well defined, and the site of immunization in the pinna
Figure 3. B cell depletion results in an increased neutrophilic and Th17 response in the lungs of C57BL/6 mice with acute TB: IL-17
neutralization reverses the neutophilia phenotype. Wild-type C57BL/6 animals or mice depleted of B cells using the CD22-cal conjugated Ab
were infected aerogenically with 200–300 CFU of M. tuberculosis Erdman; lung cells were prepared at appropriate time intervals after infection and
subjected to intracellular staining and/or flow cytometric analysis. Administration of CD22-cal resulted in ,95% depletion of CD19+ B cells in the
lungs of M. tuberculosis-infected mice at day 21 p.i. (see Figure S1A). A, The proportion and absolute number of neutrophils (CD11b+Ly6G+) among
total lung cells in mice rendered B cell-deficient by CD22-cal treatment are elevated relative to those detected in non-B cell-depleted animals
(*p,0.05, **p,0.005). B, CD22-cal-treated B cell-depleted mice, relative to untreated wild-type animals, exhibited a significant increase in total IL-17-
producing lung cells during the acute phase of tuberculous infection (*p,0.05). C, Neutralization of IL-17 in CD22-cal-treated mice reverses lung
neutrophilia phenotype associated with B cell-depletion at day 14 p.i. (*p,0.05, **p,0.005). Data depicted are representative of two to three
experiments with three to five mice per group.
doi:10.1371/journal.ppat.1003472.g003
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can be readily localized [49]. In this model, the level of neutrophil
infiltration was higher in the ears of vaccinated mMT mice relative
to that detected in wild-type animals as early as 7 days post-
vaccination (Figure 5A). The number of neutrophils at the site of
vaccination was also higher in immunized mMT mice relative to
wild-type mice (Figure 6A, Right Panel). Neutrophilia was
similarly observed in BCG vaccinated sites in the ear of mice
rendered B cell-deficient via 5D2 treatment (Figure 5B). These
data revealed that in B cell-deficient mice, pulmonic neutrophilia
observed during the acute phase of M. tuberculosis infection occurs
also at the site of ID BCG vaccination in the ear.
Since B cell deficiency is associated with sub-optimal develop-
ment of BCG-elicited Th1 response (Figure 4), and since DC
priming of CD4+ T cells is critical to the development of vaccine-
induced protection, we initiated studies to characterize the kinetics
of DC migration to the draining lymph nodes following BCG
vaccination. The results revealed that mMT or B cell-depleted
C57BL/6 mice exhibited diminished numbers of CD11c+ DCs in
the superficial cervical lymph nodes compared to wild-type
controls starting at as early as day 2 and continuing through day
7 post-vaccination (Figure 5D&F). The BCG-induced Th1
response of the two B cell-deficient mouse groups, as assessed by
the number of interferon (IFN)-c-producing CD4+ T cells in the
draining superficial cervical lymph nodes, was diminished
compared to that detected in vaccinated wild-type animals
(Figure 5C&E). These data suggest that B cell deficiency results
in impaired T cell priming following BCG immunization. The
decreased number of BCG-induced DC migrated to the draining
lymph nodes in the B cell-deficient animals could be a factor that
contributes to the impairment of CD4+ T cell priming observed in
the mMT and B cell-depleted mice.
The effects of IL-17 neutralization on the development of
BCG-induced Th1 response in B cell-deficient mice
The enhanced pinna neutrophilia and the impaired Th1
response observed in B cell-deficient mice upon BCG immuniza-
tion (Figure 5) prompted us to investigate the relationship between
these two observations. Based on the finding that lung neutrophilia
in M. tuberculosis-infected mice is Th17/IL-17 driven (Figures 2 &
3), we first examined the effect of IL-17 neutralization on BCG-
induced Th1 response in the ear immunization model. In
agreement with results obtained from the lung infection model
(Figures 2 & 3), IL-17 neutralization significantly attenuated the
BCG-induced neutrophilic response in the ear inoculation model,
reducing the number of neutrophils in the BCG-vaccination site of
C57BL/6 and B cell-deficient animals by 78% and 49%,
respectively (Figure 6A). The results indicate that IL-17 is
involved, at least in part, in neutrophil recruitment to the site of
BCG immunization in both B cell-deficient and B cell-sufficient
states.
IL-17 neutralization modulates BCG-elicited Th1 response in
wild-type and B cell-deficient mMT mice, albeit in opposing
fashion (Figure 6B). Concomitant with the decrease in neutrophilia
at the site of immunization upon IL-17 neutralization, there was
an increased BCG-elicited Th1 response in the B cell-deficient
mice (Figure 6B). By contrast, IL-17 neutralization in immunized
wild-type C57BL/6 mice resulted in a diminished Th1 response
(Figure 6B). The incongruent effects of IL-17 neutralization on the
BCG-induced Th1 response among wild-type and mMT mice
were also apparent on DC migration to the draining cervical
lymph nodes following vaccination (Figure 6C). IL-17 neutraliza-
tion during BCG immunization of mMT mice did not alter the
number of DCs in the draining cervical lymph nodes 7 days post-
immunization, but decreased that in wild-type mice (Figure 6C).
These data suggest that i) IL-17 modulates the BCG-elicited Th1
response; and ii) the enhanced IL-17/Th17 response in B cell-
deficient mMT mice upon BCG immunization contributes to the
diminished vaccine-elicited Th1 immunity. This effect could be
mediated by IL-17/Th17 per se and/or through the level of
neutrophilic infiltration at the site of vaccination. The discrepant
effects of IL-17 neutralization on vaccination-induced Th1
response in wild-type C57BL/6 and mMT mice warrant further
investigation.
Neutrophil depletion improves DC migration to and
priming of Th1 cells in draining lymph nodes
IL-17 neutralization resulted in only partial attenuation of the
neutrophilic response in the ear vaccination model (Figure 6A).
Due to this partial effect and the link between IL-17 and
neutrophilic recruitment, the IL-17 depletion approach does not
allow clear determination of the relative contribution of this
cytokine and neutrophils to the observed B cell-deficiency-
associated Th1 and DC phenotypes. To begin to address this
issue, we conducted neutrophil depletion experiments using the
Figure 4. B cell deficiency results in a diminished Th1 response in BCG-immunized mice. Wild-type or B cell-deficient mice were
vaccinated with BCG and at one month post-immunization, splenic T cells were assessed for the development of Th1 response by quantification of
IFN-c-producing CD4+ T cells. A, ELISPOT analysis of the number of splenic P25-Ag85B-specific IFN-c-producing CD4+ T cells in wild-type and mMT
mice 1 month after vaccination revealed a diminished Th1 response in the B cell deficient group (** p,0.005). B, A similarly decrease in BCG-induced
Th1 response was also observed in mice rendered B cell-deficient via treatment with the anti-CD20 5D2 mAb (***p,0.0005). Data shown are
representative of three independent experiments with four mice per group.
doi:10.1371/journal.ppat.1003472.g004
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Figure 5. B cell-deficient mice, upon ID ear immunization with BCG, display an enhanced neutrophilic infiltration in the pinna and
an attenuated Th1 response in the draining superficial cervical lymph nodes that are associated with diminished DC migration. Ears
of wild-type or B cell-deficient mice were vaccinated intradermally with BCG and assessed at the indicated time intervals post-immunization. Cells
from the ear and the draining superficial cervical lymph nodes were procured as described in Materials and Methods and subjected to flow
cytometric analysis. mMT mice (A) and C57BL/6s depleted of B cells using the 5D2 anti-CD20 mAb (B) exhibited elevated numbers of CD11b+Ly6G+
neutrophils compared to wild-type animals (*p,0.05). Results of flow cytometric analyses showed a diminished number of IFN-c-producing CD4+ Th1
cells (C) and CD11c+ DC (D) in draining superficial cervical lymph nodes of B cell-deficient mMT mice (relative to wild-type C57BL/6’s) that were
immunized intradermally in the ear with BCG (16106 CFU) (*p,0.05). This Th1 (E) and DC migration (F) phenotypes were similarly observed in mice
depleted B cells via treatment of the 5D2 anti-CD20 mAb (*p,0.05). Data shown are representative of two to three independent experiments with
four mice per group.
doi:10.1371/journal.ppat.1003472.g005
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Ly6G-specific Ab, clone 1A8 [14]. 1A8 completely depleted
neutrophils at the site of BCG immunization of both wild-type
C57BL/6 and mMT mice (Figure 7A). Neutrophil depletion
reverses the DC and Th1 phenotypes in BCG-vaccinated mMT
mice (Figure 7B&C). Treatment with 1A8 increased the number of
IFN-c-producing CD4+ T cells in the draining lymph nodes of
mMT mice on day 7 post-immunization by over two fold
(Figure 7C). Neutrophil depletion increased the number of DCs
in the draining lymph nodes of the mMT mice by three fold
(Figure 7B). Similar enhancing effects of neutrophil depletion on
the number of Th1 cells and DCs were observed in the draining
lymph nodes of BCG-vaccinated C57BL/6 mice (Figure 7B&C),
albeit to a lesser extent than mMTs. To stringently test the B cell-
specificity of these observations, we examined the effects of
neutrophil depletion on C57BL/6 mice rendered B cell deficient
using the anti-CD20 Ab 5D2. Results derived from the 5D2-based
model are similar to those obtained using the mMT mice
(Figure 7D&E).
These results strongly suggest that in the ear vaccination
model, B cells contribute significantly to the development of
vaccine-induced Th1 immunity by modulating the IL-17 driven
neutrophilic response. In the absence of B cells, neutrophils play a
dominant role in down-regulating the development of vaccine-
induced Th1 response. The mechanisms by which neutrophils
adversely affect the development of BCG-induced Th1 response
remained to be defined. One possibility is the ability of
neutrophils to internalize BCG, thereby competing with DCs
(the primary antigen presenting cell (APC) responsible for the
initiation of the anti-TB immune response) for antigens, which
could result in a sub-optimal antigen dose required for T cell
priming in lymph nodes. In support of this notion, bacterial load
in the draining cervical lymph nodes of B cell-deficient mMT and
5D2-treated mice is lower than that of wild-type C57BL/6 mice
(Figure 7F).
Immune serum therapy in mMT mice reverses the
neutrophil and Th17 phenotypes
Previously we have shown that adoptively-transferred B cells
(derived from M. tuberculosis-infected wild-type C57BL/6 mice)
into mMT mice with TB effectively reverses the lung phenotypes
Figure 6. Effect of IL-17 neutralization on the level of neutrophilic infiltration in the ear and on the DC migration to and the Th1
response in the draining cervical lymph nodes of mice following ID BCG ear immunization. A, The frequency (Left Panel) and absolute
number (Right Panel) of neutrophils (CD11b+Ly6G+) in the ear dermis of B cell-deficient mMT mice on day 7 following BCG vaccination was increased
relative to that observed in wild-type C57BL/6 animals. In these studies, cells obtained from the vaccinated ears were pooled for analysis. The
enhanced pinna neutrophilic response was attenuated upon IL-17 neutralization. Upon ID ear vaccination, the B cell-deficient mMT mice exhibited
decreased number of IFN-c-producing CD4+ Th1 cells (B) and CD11c+ DC cells (C) in the draining superficial cervical lymph nodes of mMT mice relative
to those detected in wild-type C57BL/6’s. While IL-17 neutralization increased the number of Th1 cells (B) in the draining cervical lymph nodes of mMT
mice intradermally immunized in the ear, it had no apparent effects on the number of DC (C). By contrast, IL-17 neutralization attenuated DC
migration (C) to and the Th1 response (B) in the draining cervical nodes of wild-type C57BL/6 mice (*p,0.05, ***p,0.0005). The data are
representative of two independent studies with four mice per group.
doi:10.1371/journal.ppat.1003472.g006
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Figure 7. Neutrophil depletion in wild-type and B cell-deficient mice results in enhanced DC migration to and an increased Th1
response in the draining superficial cervical lymph nodes upon ID ear BCG immunization. C57BL/6 wild-type and mMT B cell-deficient
mice, as well as animals depleted of B cells by treatment with the 5D2 anti-CD20 mAb were vaccinated with 106 CFU of BCG at the ear intradermally.
Lymph nodes cells were procured at day 7 post-immunization and subjected to flow cytometric and IFN-c ELISPOT assay analyses (using the Ag85B
P25 peptide as antigens). A, mMT mice (Left Panel) and C57BL/6s depleted of B cells using the 5D2 anti-CD20 mAb (Right Panel) exhibited elevated
numbers of CD11b+Ly6G+ neutrophils at the site of ID ear BCG vaccination compared to wild-type animals. The neutrophilia in both groups of mice
was abrogated upon treatment with the Ly6G-specific mAb 1A8. 1A8 depletion of neutrophils resulted in increase in the numbers of CD11c+ DC (B)
and IFN-c-producing CD4+ T cells (C, Left Panel: intracellular staining; Right Panel: Ag85B P25 peptide-specific ELISPOT assay) in the draining cervical
lymph nodes of both the ear BCG-vaccinated mMT and wild-type C57BL/6 mice (*p,0.05, **p,0.005, ***p,0.0005). Neutrophil depletion with 1A8
led to similar enhancement of DC migration (D) to and Th1 response (E: Left Panel: intracellular staining; Right Panel: Ag85B P25 peptide-specific
ELISPOT assay) in the cervical draining lymph nodes post ID BCG vaccination in the ear of both wild-type and 5D2-treated B cell-deficient mice
(*p,0.05, **p,0.005, ***p,0.0005). F, CFU enumeration in the draining superficial cervical lymph nodes at 7 days post-BCG immunization revealed
decreased bacterial load in the mMT mice and animals depleted of B cells using the 5D2 anti-CD20 mAb (*p,0.05, ****p,0.00005). The results shown
are representative of two independent experiments. Four mice per group were used in each experiment.
doi:10.1371/journal.ppat.1003472.g007
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associated with B cell-deficiency (including neutrophilia) during
acute TB [1]. That the transferred B cells are able to reverse
pulmonic phenotypes of infected mMT mice without homing to
the lungs suggests regulation via a soluble factor(s). In that same
study, the transfer of B cells resulted in the appearance of Igs in the
recipient mMT mice [1]. These results suggest the possibility that
Igs may be one factor that can reverse the B cell-deficiency
phenotypes, including neutrophilia. In support of this possibility,
results generated from an M. tuberculosis infection model involving
FccR knockout mouse strains strongly suggest that humoral
immunity can regulate host responses (including tissue neutrophil-
ia) to the tubercle bacillus [2]. To begin testing the Ig hypothesis,
we conducted serum therapy study, which revealed that treatment
of tuberculous B cell-deficient mMT mice with immune sera
derived from M. tuberculosis-infected wild-type animals reversed the
lung neutrophilia phenotype (Figure 8A). This serum therapy also
resulted in a decrease in the number of Th17 cells in the lungs of
treated tuberculous mMT mice (Figure 8B). The data suggest that
components of the immune serum, possibly Igs, may play a role in
regulating the neutrophil and Th17 response during acute M.
tuberculosis infection.
Discussion
Cell-mediated immunity is well established as critical in defense
against M. tuberculosis [50,51,52]. By contrast, the significance of B
cells and humoral immunity in shaping the immune response to
the tubercle bacillus is less clear [37,53,54]. Studies using B cell-
deficient mMT mice, in conjunction with B cell transfer, have
provided evidence that B cells and the humoral immune response
can modulate anti-tuberculous immunity, including the level of
granulomatous inflammation and neutrophilic infiltration in lungs
[1]. FccR knockout mouse studies suggest that humoral immunity
can influence development of Th1 responses during M. tuberculosis
infection [2]. The data of the present study add the IL-17/Th17/
neutrophils axis to the list of immunological factors regulated by B
cells and humoral immunity in TB.
The results generated in two different models (lung M.
tuberculosis infection and the ear ID BCG vaccination) involving
mMT and C57BL/6 mice rendered B cell-deficient via treatment
with two independent B cell-depleting agents, revealed B cell-
dependent tissue neutrophilia at the site of interaction between
mycobacteria and the host. These observations, together with data
yielded by the IL-17 neutralization and neutrophil depletion
experiments, provided strong evidence that i) B cells regulate
neutrophilia during M. tuberculosis infection and BCG immuniza-
tion; ii) exuberant early neutrophilia can adversely affect vaccine-
induced Th1 response by impairment of DC migration to draining
lymph nodes, thereby compromising CD4+ T cell priming; and as
a result, iii) B cells can optimize BCG-elicited Th1 immunity by
regulating the IL-17/neutrophil response. Neutrophilia in the
lungs of tuberculous mMT mice is apparent as early as 7 days p.i.,
which is prior to an increase in the number of total lung IL-17-
producing cells (observed on day 21 post-aerosolization), suggest-
ing the possibility that IL-17-independent mechanisms are
involved in the regulation of B cell dependent lung neutrophilia
[55]. The decrease in the number of DCs in the draining lymph
Figure 8. Passive transfer of immune serum into B cell-deficient mice reverses the neutrophil and Th17 phenotypes. B cell deficient
mMT mice were aerogenically infected with 100–300 CFU of M. tuberculosis Erdman and lung neutrophilia assessed at 1 month p.i.. Mice were treated
with immune sera produced from tuberculous wild-type C57BL6 mice at one month post-aerosol infection, Passive transfer of immune serum from
infected wild-type C57BL/6 mice into tuberculous mMT mice resulted in diminished lung neutrophil infiltration (A, * p,0.05) and Th17 response (B,
*p,0.05, **p,0.005, ***p,0.0005) at 1 month p.i.. The results of three neutrophil and two Th17 experiments are shown. Four mice per group were
used in all experiments.
doi:10.1371/journal.ppat.1003472.g008
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nodes of vaccinated B cell-deficient mice suggests that excess
neutrophilia at the site of vaccination can result in competition
between neutrophils and DCs for BCG, thereby affecting vaccine
dosage and likely DC maturation and hence migration to the
lymph nodes. This notion is supported by the decrease in bacterial
burden in the draining lymph nodes of immunized B cell-deficient
mice. It is, however, possible that the antigen uptake and
migration capacity of the DCs at the site of immunization of a B
cell-deficient host, is adversely affected, directly or indirectly, by
the excessive neutrophilia (independent of the BCG competition
theory) that occurs in the dermis of the vaccinated ear. The results
that IL-17 neutralization with concomitant decrease in neutro-
philia improves Th1 response in BCG-vaccinated mMT mice
without affecting the number of lymph node DCs suggest the
possibility that the immunization site in the ear of the mMT mice
provides a local environment, of which excessive neutrophilia is a
feature, can qualitatively compromise the capacity of DCs to
effectively prime CD4+ T cells.
The opposing effects of IL-17 neutralization on BCG-elicited
Th1 response in vaccinated wild-type and mMT mice are
intriguing. The results generated by the IL-17 neutralization
experiments involving wild-type mice are, in fact, in agreement
with a previous study reporting that IL-17 can drive BCG-elicited
Th1 response [29]. The discrepant effects of IL-17 neutralization
observed among wild-type and mMT mice in the BCG vaccination
model could be secondary to differences in the level of the IL-17
response and to the dissimilarities in the quantity and quality of
neutrophils at the immunization site among the two mouse groups,
with the level of neutrophilia in the ear dermis of B cell-deficient
mMT strain being significantly greater than that detected in the
C57BL/6 wild-type mice. These same variables could result in the
differential effect of IL-17 neutralization on the number of DCs in
the draining lymph nodes of the two mouse groups. It will be of
interest to determine the functional properties of the neutrophils
infiltrating the immunization sites of the mMT and wild-type mice.
Collectively, the IL-17 neutralization studies have provided
evidence that B cells can optimize BCG-induced Th1 immunity
by modulating the IL-17/neutrophil response.
Results of the neutrophil depletion experiment support a role
for these cells in regulating development of Th1 responses during
vaccination. It has been reported recently that neutrophils
enhance CD4+ T cell priming in the early phase of an aerogenic
M. tuberculosis lung infection by promoting DC migration to
draining mediastinal lymph nodes [8]. In the ear ID BCG
immunization model employed here, neutrophil depletion en-
hances the vaccine-induced Th1 response. The discrepant data
regarding the role of neutrophils in modulating CD4+ T cell
priming could be due to the obvious multiple variables in the two
models employed, including but not limited to the differences in
the strains of mycobacteria studied (BCG versus M. tuberculosis), in
the quality of the DCs (lungs versus skin), and in the conditions in
which the mycobacteria interact with the host (lungs parenchyma
versus dermis). In a Leishmania major model involving ID ear
infection of metacyclic promastigotes, neutrophil depletion also
results in enhanced priming of pathogen-specific CD4+ T cells
[56].
By contrast and worthy of note, the observation that IL-17-
neutralized C57BL/6 mice displayed a decrease in BCG-induced
Th1 response and in the number of DCs in draining lymph nodes
lends indirect support to the recently reported role for neutrophils
in promoting T cell priming in acute TB [8], since IL-17
neutralization decreases the number of neutrophils at the site of
immunization in the ear vaccination model. These contrasting
observations of the IL-17 neutralization and the neutrophil
depletion studies could be due to differences in the immunological
environment resulting from IL-17 neutralization versus neutrophil
depletion. For example, IL-17 neutralization results in partial
decrease in the degree of neutrophilia at the site of immunization
and in the level of IL-17, while 1A8 treatment results in virtually
complete depletion of neutrophils without apparent interference
with the amounts of IL-17. Together, the results also suggest that
the complex roles of neutrophils in development of immune
response to M. tuberculosis could depend on the characteristics of
the site of immunological reaction, the level of neutrophilia as well
as the interaction with other immune molecules. Understanding
the mechanisms underlying the differential effects of neutrophil
depletion on the development of the Th1 response in the lung
infection and ear immunization model may shed light on the
requisites for the development of optimally efficacious anti-TB
vaccines.
The precise mechanisms by which B cells regulate the IL-17
response remain to be determined. The effects of IVIG
(intravenous immunoglobulins) treatment on M. tuberculosis-infect-
ed mice [57] and results obtained from the FccRIIB- and Fcc
chain-deficient mouse TB models strongly support a role for Igs in
regulating anti-TB immunity, including the Th1 response [2]. The
notion is further supported by the ability of adoptively transferred
B cells from infected C57BL/6 mice to reverse neutrophilia in the
lungs of infected mMT mice without having to home to the lungs
[1]. In the current study, we demonstrate that immune sera from
infected mice can reverse the lung neutrophilia and Th17
phenotypes in B cell-deficient mice with TB. It is thus tempting
to speculate that Igs, known effective modulators of inflammation
[53,58], are a factor in the immune sera with the capacity to
ameliorate the B cell-deficiency associated neutrophilia and Th17
phenotypes. We are cognizant of the complex nature of sera and
as such, much work needs to be done in order to establish or refute
a role for Igs in regulating the neutrophilic response in a
tuberculous host. Experiments designed to address this issue are
currently underway.
In summary, results of the present study provide strong evidence
that B cells can regulate tissue neutrophilia during M. tuberculosis
infection and BCG vaccination by modulating the IL-17 response.
In addition, the study has provided evidence that the compromised
BCG-induced Th1 response associated with B cell-deficiency is
secondary to neutrophilia. These observations suggest that B cells
can optimize BCG-elicited Th1 immunity by regulating the IL-
17/neutrophilic response. It appears that optimally effective
immunization protocols should achieve a balanced level of IL-
17/neutrophilic response, which can only be achieved through a
comprehensive understanding of the biology of these two
immunological elements. Elucidation of the mechanisms by which
B cells regulate the IL-17/neutrophilia response in M. tuberculosis-
host interaction may help the design of novel effective TB vaccines
and of protocols for the treatment of inflammatory disorders. Last
but not least, the overall congruent results of the mMT and B cell
depletion experiments suggest the validity of the use of the mMT
mouse to investigate the role of B cells and humoral immunity in
the development of anti-mycobacterial immune responses [1].
Materials and Methods
Ethics statement
Animal studies were conducted in accordance to the National
Institutes of Health guidelines in compliance with assurance of the
well being of laboratory animals. All protocols used in the study
have been approved by the Institutional Animal Care and Use
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Committee of Albert Einstein College of Medicine (protocol #
20110602).
Animals
Female C57BL/6 mice (Charles River Laboratories) and B cell-
deficient mice (mMT; Jackson Laboratories) [46], 8–10 weeks old,
were used in all experiments. Infected mice were housed in our
biosafety level-3 laboratory and kept pathogen-free by routine
serological and histopathological examinations. Animal protocols
employed in this study were approved by the Institutional Animal
Care and Use Committee of Albert Einstein College of Medicine.
Mycobacteria, mouse infection, and determination of
tissue bacterial burden
Bacterial stocks of M. tuberculosis strain Erdman (Dr. Frank
Collins, Trudeau Institute, Saranac Lake, NY) were generated by
passaging through mice to maintain virulence as previously
described [1]. Bacteria were stored at 280uC in aliquots until
use. Mice were infected with 100–300 colony forming units (CFU)
of M. tuberculosis via aerosol inhalation using a Glas-Col inhalation
chamber to deliver the desired inoculum [59]. For each
experiment, the accuracy of inoculum dose was confirmed by
assessing the number of bacterial colonies upon plating serial
dilutions of whole lung homogenates on 7H10 agar plates (Difco)
as previously described [1]. Tissue bacterial burden was quantified
as previously described by plating serial dilutions of lung, liver, and
spleen homogenates onto 7H10 agar plates at appropriate
intervals after infection [1]. Tissue bacterial load was determined
by counting the number of colonies on 7H10 agar plates after
incubation at 37uC for 4 to 6 weeks.
Preparation of single-cell suspension from tissues
Single cell suspensions were prepared as previously described
[1]. Briefly, aseptically procured lungs, spleen, or lymph nodes
were dissected at appropriate times after exposure to mycobacte-
ria, then minced using sterile razor blades (Fisher Scientific) in cold
RPMI 1640 with L-glutamine supplemented with 25 mM
HEPES, 10% fetal bovine serum (FBS; GIBCO), and 55 mM 2-
mercaptoethanol (complete RPMI). Minced lung tissues were then
incubated in 1 mg/mL collagenase and 30 mg/mL DNase (Sigma
Aldrich) at 37uC for 30 min. Digested tissues were passed through
a 70-mm pore nylon cell strainer (Falcon; BD Biosciences) using the
flat end of a sterile syringe plunger. The resultant cell suspensions
were then treated with ACK lysis buffer (Invitrogen) to lyse red
blood cells. Cells were then washed twice with complete RPMI.
The method of trypan blue exclusion was used to enumerate live
cells. For the ID model of immunization, ear dermal sheets were
split along the cartilage and placed skin-side up in RPMI complete
supplemented with 10% FCS and collagenase (1 mg/mL),
followed by an one-hour incubation at 37uC and 5% CO2 to
prepare suspensions of cells. Single cell suspensions were obtained
by filtering through a 70-mm cell strainer (BD Falcon).
Flow cytometry and intracellular staining
Single cell suspensions prepared from various tissues as
described above, were washed in Flow Cytometry Staining Buffer
(eBioscience). Flow cytometric analysis and intracellular staining
was conducted as previously described [1,2]. For each sample,
approximately 106 cells were suspended in Flow Cytometry
Staining Buffer. Cellular Fcc receptors were blocked by incubating
cells in Fc block (BD Biosciences) on ice for 10 min. Cells were
then immunostained for flow cytometric analysis with the
following fluorochrome-conjugated Abs: anti-CD4-PE-Cy7 (clone
RM4-5), anti-CD11c-FITC (clone HL3), anti-CD11b-PE-Cy7
(clone M1/70), anti-Ly6G-FITC (clone 1A8), B220-PerCP (clone
RA3-6B2), CD22-PE (clone Cy34.1), CD19-FITC (clone 1D3),
anti-IFN-c-PE (clone XMG1.2), and anti-IL-17A-PE (clone
TC11-18H10), all from BD Pharmingen; and anti-CD3-APC
(clone 145-2C11; eBioscience). Dead cells were excluded from
analysis using the LIVE/DEAD Fixable Violet Dead Cell Stain
Kit (Invitrogen) according to manufacturer’s protocol. Samples
were collected on an LSRII (BD Biosciences, San Jose, CA), and
data analysis was performed using FlowJo software (TreeStar,
Ashland, OR). To stain for intracellular cytokines, single lung cell
suspensions prepared as described above were stimulated in wells
of 96-well plates in RPMI-1640 with 10% (vol/vol) FBS for
2 hours at 37uC and 5% CO2 in the presence of PMA (50 ng/mL)
and ionomycin (500 ng/mL). Brefeldin A (1 mg/mL; eBioscience)
was then added to the wells, and incubation was continued for
another 2 hours at 37uC and 5% CO2. Following stimulation, the
FoxP3 staining buffer kit (eBioscience) was used according to the
manufacturer’s protocol for intracellular cytokine staining.
B cell depletion
For B cell depletion studies, two different reagents were used to
deplete this lymphocytes population from wild-type C57BL/6
mice. The first reagent, CD22-cal (Pfizer), is an immunoconjugate
consisting of a monoclonal antibody (mAb) that reacts specifically
with mouse CD22 (a B cell-specific surface molecule), conjugated
to N-acetyl-calicheamicin dimethyl acid, an enediyne anti-tumor
agent [47,48] that mediates dose-dependent cytotoxicity upon
internalization [60,61]. CD22-cal was administered at a dose of
160 mg/kg intraperitoneally (i.p.) at 12 and 7 days before M.
tuberculosis infection, and then at 9 and 14 days post-inoculation.
This regimen has been shown in various mouse models to
effectively deplete B lymphocytes without affecting other immune
cells [47]. This CD22-cal protocol routinely attains ,95% of
splenic B cell-depletion in treated mice at the time of M. tuberculosis
infection and subsequent time intervals of analysis (Figure S1A and
data not shown). 5D2, an anti-CD20 mAb (Genentech), was
another B cell-depleting agent used. Mice received a dose of
10 mg/kg of Ab intravenously two days prior to ID ear or SC
BCG immunization. Two weeks after the initial dose, anti-CD20
5D2 was then given i.p. at a dose of 5 mg/kg every other week for
maintenance. This 5D2 protocol was shown in pilot experiments
to be highly effective in B cell-depletion in mycobacteria-infected
mice (Figure S1B).
The BCG immunization models
BCG immunization was administered either subcutaneously or
intradermally. For the conventional SC vaccination model, 106
BCG Pasteur were inoculated subcutaneously in the scruff of the
back of the neck in 100 ml of PBS containing 0.05% Tween-80
(Sigma Aldrich). For the ID vaccination model, an inoculum of
106 BCG (determined in standardization experiments to be the
optimal dose), in 10 ml of PBS containing 0.05% Tween-80 (Sigma
Aldrich), was injected intradermally into the ear pinna of
anesthetized mice using a Hamilton Microlitre syringe. Single cell
suspensions of splenocytes and of the pinna and draining lymph
nodes were obtained as described above and subjected to the IFN-
c ELISPOT assay (see below) and flow cytometric analysis.
IFN-c ELISPOT assays
The IFN-c ELISPOT assay was used to assess the CD4+ T cell
response upon exposure to mycobacteria as previously described
[62]. T cells were purified from appropriate tissues at the desired
time intervals using the Mouse Pan T Cell Isolation Kit II
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(Miltenyi Biotech). Detection of IFN-c-producing T cells was
conducted using the Mouse IFN-c ELISPOT Ready-Set-Go Kit
(eBioscience) according to manufacturer’s instructions. Briefly, T
cells (16105 and 36105) were seeded in wells of 96-well ELISPOT
plates (Millipore) that had been coated overnight with IFN-c
capture Ab. Peptide 25 (aa 240–254) of M. tuberculosis antigen 85B
(P25-Ag85B) was used to stimulate CD4+ T cells [62]. Splenocytes
from naı¨ve uninfected mice were used asAPCs. The APCs were
pulsed with P25-Ag85B (10 mg/mL) for 1 hour at 37uC and 5%
CO2, washed twice, and added to T cell-seeded wells (2610
5 cells
per well). T cells co-cultured with unpulsed APCs served as
controls. After a thirty-six-hour incubation at 37uC and 5% CO2,
cells were removed and the captured cytokine was detected using a
biotinylated anti-mouse IFN-c Ab (clone R4-6A2; eBiosciences).
Avidin-horseradish peroxidase (eBioscience) was added to the wells
for 45 minutes at room temperature and colorization was achieved
using AEC substrate solution (eBioscience). The substrate reaction
was stopped by washing the plate with distilled water. Spots were
enumerated using an automated ELISPOT reader.
In vivo IL-17 neutralization
Two anti-mouse IL-17 mAb’s were used. One was obtained
from R & D systems (50104; IgG2) and another from Genetech
(IgG1; Gift of Dr. Wenjun Ouyang, Genentech). The mAb’s were
administered was administered i.p. at a dose of 100 mg per mouse
(in 200 ml of sterile PBS) every 3–4 days starting one day before M.
tuberculosis infection or BCG immunization for the duration of the
study. This regimen has been shown to effectively neutralize IL-17
in various experimental models [63]. Control groups received
matched IgG isotypes.
In vivo neutrophil neutralization
For neutrophil depletion, the anti-mouse Ly6G Ab (BioXcell;
clone 1A8) or Rat IgG2 a isotype control (BioXcell; clone 2A3),
200 mg per mouse in 100 ml of sterile PBS, was administered i.p.
every 3–4 days as previously described [64] starting one day before
BCG immunization for the duration of the study.
Passive serum transfer experiments
Blood was collected retro-orbitally from C57BL/6 mice infected
with 100 CFU M. tuberculosis Erdman at 1 month p.i.. Sera were
collected after clarification by centrifugation of clotted blood and
stored at 280uC until use. Sera thus collected are referred to as
immune sera. One hundred ml of immune sera were administered
i.p. every 3–4 days into mMT mice, starting 1 day before infection
with 100–300 CFU of M. tuberculosis Erdman, and continued for 1
month thereafter. At 1 month p.i., lung cells were procured from
mice and subjected to intracellular staining and flow cytometric
analysis.
Statistical analysis
Where appropriate, the statistical significance of data points was
determined using the unpaired Student t test or ANOVA analysis,
assessed using GraphPad Prism 5 software. A p value of,0.05 was
considered significant.
Supporting Information
Figure S1 B cell depletion in C57BL/6 mice using CD22-
cal and the 5D2 anti-CD20 Abs. A, Administration of CD22-
cal according to the protocol described in Materials and Methods
resulted in ,95% depletion of CD19+ B cells in the lungs of M.
tuberculosis-infected mice at day 21 p.i.. B, Administration of the
5D2 anti-CD20 mAb according to the protocol described in
Materials and Methods led to effective B cell depletion (,97%
depletion) at the start of M. tuberculosis aerogenic infection of
C57BL/6 mice that was maintained for the duration of the
experiment (4 weeks p.i.). Results shown are representative of 2
independent experiments with 3 mice in each experimental group.
WT: wild-type C57BL/6 mice treated with isotype control Abs.
(TIF)
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